Search Results 51-60 of 17266 for hba1c

  1. Study Evaluating The Efficacy And Safety Of Obeticholic Acid In Subjects With Compensated Cirrhosis Due To Nonalcoholic Steatohepatitis - Mayo Clinic

    HbA1c ≥ 9.5% within 90 days before Day 1. LDL cholesterol ≥ 190 mg/dL and already on a stable dose of LDL-lowering medication for ≥ 30 days. LDL ...

  2. Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Oversight Control in Type 1 Diabetes - Mayo Clinic

    HbA1c ≥6.5% documented iv. Random glucose ≥200 mg/dL with symptoms v. No data at diagnosis is available but the participant has a convincing history of ...

  3. A Study to Evaluate the Effect of Hyperoxia on Glucose Metabolism in Type 2 Diabetics - Mayo Clinic

    HbA1c 6.5% -9.5%; FPG ≥126 mg/dL (7.0 mmol/L) <270 mg/dl at screening; 25 to 60 years of age; BMI 22-37 kg/m². Exclusion Criteria. Diabetic meds other than ...

  4. Butyrate Adjuvant Therapy for Type 1 Diabetes - Mayo Clinic

    Will also meet HbA1c level of 6.4-8.9% and BMI of < 30 kg/m2 at week -4. Exclusion Criteria: 1. Except for the use of insulin, no other treatments for T1D ...

  5. Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes - Mayo Clinic

    * HbA1c less than 6.5% * Use of any glucose-lowering agents including metformin or sulfonylureas. * For female subjects: positive pregnancy test at the time ...

  6. Study of Critical Outcomes in Pregnant Patients on Insulin Pump with Type 1 Diabetes - Mayo Clinic

    HbA1c ≥ 6.5% documented;; Random glucose ≥ 200 mg/dL with symptoms;; No data at diagnosis is available but the participant has a convincing history of ...

  7. Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes - Mayo Clinic

    Diabetic subjects with HbA1c concentrations of ≤ 8%. Diabetic subjects will be either on diet and lifestyle therapy alone, or monotherapy with metformin or ...

  8. Risk Prediction For Immune Checkpoint Inhibitor Associated Diabetes Mellitus - Mayo Clinic

    New onset of diabetes mellitus any time after initiating ICI therapy based on criteria: HbA1c >6.4 % or FPG ≥126mg/dl on two occasions or OGTT >199 on two ...

  9. Diabetes - Symptoms and causes - Mayo Clinic

    Diabetes mellitus refers to a group of diseases that affect how the body uses blood sugar (glucose). Glucose is an important source of energy for the cells that ...

  10. Impact Of Aromatase Inhibitor Therapy On Glucose Homeostasis And Diabetes Risk - Mayo Clinic

    ... HbA1c ≥ 6.5% * History of upper GI surgery that alters gastric emptying or causing malabsorption e.g., bariatric surgery, fundoplication. Note: Other ...